Skip to main content

Table 4 Differences between subjects with psoriasis with or without MS

From: Metabolic syndrome and its components in patients with psoriasis

  MS No MS P
Mean ± SD Mean ± SD
Median (minimal-maximal values) Median (minimal-maximal values)
Age (years) 55.45 ± 11.28 42.69 ± 13.16 <0.001
BMI (kg/m2) 30.5 (22.5-41.79) 25.52 (18.9-36.36) <0.001
HOMA Index 3.79 (1.07-22.73) 1.94 (0.85-6.97) <0.001
Age at time of diagnosis (years) 34.25 ± 16.29 24.6 ± 13.5 0.002
Time of evolution (years) 20 (0.5-55) 15 (1-51) ns
PASI Index 6.95 (0-35) 4.8 (0-36.3) ns
Moderate - Severe Psoriasis 24/53 (45.2%) 18/48 (36.7%) ns
Psoriatic Arthritis (%) 22.64% 18.3% ns
Topical corticosteroids 54.71% 71.4%  
Immunosupressors 4 methotrexate 1 leflunamide
  1 methotrexate + deflazacort  
Biolological treatment - 2 adalimumab
  1. BMI: body mass index. PASI Psoriasis Area and Severity Index.